Drug Production News and Research

RSS

Laboratorios Grifols, Cadence announce new supply agreement for OFIRMEV

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags.

6 Mar 2013

IOM proposes state, FDA actions to stop growth of counterfeit drugs

The Institute of Medicine Wednesday urged a series regulatory changes to help protect the public against buying fake or poorly made drugs.

15 Feb 2013

Mass. adopts stricter rules, penalties for compounding pharmacies

The emergency regulations will allow the state to monitor contamination and the volume of medicines being made.

3 Nov 2012

Derma Sciences to initiate DSC127 Phase 3 program in diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported that based on a meeting held last week with the U.S. Food and Drug Administration (FDA), the Company plans to begin its Phase 3 program in December 2012 in support of a New Drug Application (NDA) for DSC127 for treatment of diabetic foot ulcers.

23 Oct 2012

Challenges to India's role as global pharmaceutical supplier

"India has had a positive global impact through its supply of vast quantities of low-cost, good-quality generic medicines, which have saved or prolonged millions of lives ... but there are also many factors that may hinder the continuation of the country's role as chief supplier of medicines to developing countries," Martin Khor, executive director of the South Centre in Geneva, writes in an Inter Press Service opinion piece.

27 Sep 2012

AIDS battle: stretching use of anti-HIV drugs

A Johns Hopkins expert in the drug treatment of HIV disease and AIDS is spearheading an international effort to radically shift the manufacturing and prescribing of combination therapies widely credited in the last decade for keeping the disease in check for 8 million of the 34 million infected people worldwide.

5 Jul 2012

Siemens announces integrated imaging solution for detection of amyloid plaques

Siemens Healthcare is the first company worldwide to announce a complete integrated diagnostic imaging solution proposed for the detection of amyloid plaques — one of the necessary pathological features of Alzheimer's disease— in the living brain.

From Siemens Healthineers 11 Apr 2012

Health solutions developed in lower-income countries will help bring end to aid

"It is not just quantity of aid that counts nowadays, but the quality and perspective of that aid, as well as innovation, investment and experience domestically," Jonathan Glennie, a research fellow at the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog."

27 Mar 2012

Actelion, Auxilium partner to develop and commercialize XIAFLEX

Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. announced today that they have entered into a long-term partnership for the development, supply and commercialization of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the potential treatment of Dupuytren's contracture and Peyronie's disease.

23 Feb 2012

Anesthesia drug shortages can have devastating impact on patient care

The United States is facing ongoing shortages of several critical anesthesia medications—shortages with potentially serious effects on patient care and safety, according to a special article in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Nov 2011

Obama takes action to address drug shortages

President Barack Obama issued an executive order Monday directing the Food and Drug Administration to, among other steps, speed up reviews of manufacturers' applications to begin or alter production of a drug in potentially short supply.

2 Nov 2011

Researchers announce new method to build important heparin drug

Robert Linhardt is working to forever change the way some of the most widely used drugs in the world are manufactured. Today, in the journal Science, he and his partner in the research, Jian Liu, have announced an important step toward making this a reality. The discovery appears in the October 28, 2011 edition of the journal Science in a paper titled "chemoenzymatic synthesis of homogeneous ultra-low molecular weight heparins."

28 Oct 2011

NanoViricides President completes stock sales program

NanoViricides, Inc. announced that its President, Dr. Anil Diwan, has completed the programmed sale of the NanoViricides stock that he had obtained as a founder.

18 Oct 2011

Pew Health Group to ensure safety of U.S. drug supply

On Wednesday, September 14, Allan Coukell, a pharmacist and director of medical programs at the Pew Health Group, will testify before the Senate Health Education Labor and Pensions Committee about the need for Congressional action to ensure the safety of the U.S. drug supply.

12 Sep 2011

Drugs produced in offshore manufacturing plants more likely to have quality problems

Drugs produced in offshore manufacturing plants -- even those run by U.S. manufacturers -- pose a greater quality risk than those prepared in the mainland United States, a new study suggests.

7 Sep 2011

Foreign drug manufacturing, testing raise regulatory and ethical concerns

JAMA discusses "a recent report from the Pew Health Group about the growing risks of substandard and counterfeit medications resulting from the increasing overseas production of pharmaceuticals and their ingredients."

25 Aug 2011

Protox reports net loss of $3.2 million for second quarter 2011

Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.

10 Aug 2011

Pharmalucence selects Bosch to provide isolated filling line for Billerica production facility

Pharmalucence, Inc. has selected Robert Bosch Packaging Technology, Inc. to provide a state-of-the-art isolated pharmaceutical filling line for the new Pharmalucence production facility being constructed in Billerica, MA.

30 Jul 2011

USANA receives FDA registration to manufacture OTC drugs

USANA Health Sciences, Inc. today announced it has obtained the U.S. Food and Drug Administration's "Drug Establishment Registration," allowing the company to manufacture over-the-counter (OTC) drugs and holding it to a standard well above what is required of a dietary supplement manufacturer.

11 Jul 2011

New technologies could bring innovative sensors, devices for 'lab-on-a-chip' applications

Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.

6 Jul 2011